| Literature DB >> 34940487 |
Ivan V Lukiev1,2, Ludmila S Antipina3, Semen I Goreninskii1,4, Tamara S Tverdokhlebova1, Dmitry V Vasilchenko3, Anna L Nemoykina5, Daria A Goncharova6, Valery A Svetlichnyi6, Georgiy T Dambaev3, Vyacheslav M Bouznik7,8, Evgeny N Bolbasov1,9.
Abstract
In the present study, wound healing ferroelectric membranes doped with zinc oxide nanoparticles were fabricated from vinylidene fluoride-tetrafluoroethylene copolymer and polyvinylpyrrolidone using the electrospinning technique. Five different ratios of vinylidene fluoride-tetrafluoroethylene to polyvinylpyrrolidone were used to control the properties of the membranes at a constant zinc oxide nanoparticle content. It was found that an increase of polyvinylpyrrolidone content leads to a decrease of the spinning solution conductivity and viscosity, causing a decrease of the average fiber diameter and reducing their strength and elongation. By means of X-ray diffraction and infrared spectroscopy, it was revealed that increased polyvinylpyrrolidone content leads to difficulty in crystallization of the vinylidene fluoride-tetrafluoroethylene copolymer in the ferroelectric β-phase in membranes. Changing the ratio of vinylidene fluoride-tetrafluoroethylene copolymer and polyvinylpyrrolidone with a constant content of zinc oxide nanoparticles is an effective approach to control the antibacterial properties of membranes towards Staphylococcus aureus. After carrying out in vivo experiments, we found that ferroelectric hybrid membranes, containing from five to ten mass percent of PVP, have the greatest wound-healing effect for the healing of purulent wounds.Entities:
Keywords: electrospinning; ferroelectrics; nanofibers; wound healing
Year: 2021 PMID: 34940487 PMCID: PMC8704805 DOI: 10.3390/membranes11120986
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Figure 1SEM images and water contact angles of VDF-TeFE/ZnO membranes with various PVP content: (A) 0 wt%; (B) 10 wt%; (C) 40 wt%.
Spinning solution viscosity and average fiber diameter, tensile strength, and elongation of the fabricated materials with various PVP contents.
| PVP Content, % | Dynamic Viscosity, | Conductivity, µS/cm | Mean Fiber Diameter, µm | Tensile | Elongation, % |
|---|---|---|---|---|---|
| 0 | 51.9 ± 4.3 | 43.5 ± 1.0 | 0.36 ± 0.09 | 13.4 ± 0.8 | 70.0 ± 6.8 |
| 5 | 60.3 ± 2.5 | 38.2 ± 0.6 | 0.47 ± 0.11 | 10.9 ± 0.7 | 42.6 ± 4.7 |
| 10 | 52.8 ± 3.9 | 33.9 ± 0.7 | 0.41 ± 0.12 | 8.6 ± 1.1 | 59.9 ± 6.4 |
| 20 | 28.0 ± 1.5 | 32.8 ± 0.5 | 0.40 ± 0.08 | 9.2 ± 0.4 | 41.0 ± 3.4 |
| 40 | 6.3 ± 0.4 | 34.5 ± 0.5 | 0.32 ± 0.09 | 6.8 ± 0.7 | 36.8 ± 6.6 |
Chemical composition of the fabricated membranes, studied by the EDX method, at%.
| PVP | C | F | O | N | Zn | F/C | F/O |
|---|---|---|---|---|---|---|---|
| 0 | 53.1 ± 1.5 | 41.3 ± 1.7 | 3.1 ± 0.2 | - | 2.6 ± 0.1 | 0.80 ± 0.05 | 13.56 ± 1.22 |
| 5 | 56.6 ± 2.5 | 36.4 ± 2.8 | 3.7 ± 0.1 | 0.7 ± 0.2 | 2.6 ± 0.1 | 0.64 ± 0.08 | 9.84 ± 0.98 |
| 10 | 59.9 ± 2.1 | 33.0 ± 2.3 | 4.1 ± 0.1 | 1.4 ± 0.1 | 2.5 ± 0.1 | 0.56 ± 0.06 | 8.10 ± 0.61 |
| 20 | 60.3 ± 0.4 | 29.1 ± 0.6 | 5.3 ± 0.2 | 2.7 ± 0.1 | 2.5 ± 0.1 | 0.48 ± 0.01 | 5.50 ± 0.29 |
| 40 | 66.6 ± 1.8 | 17.8 ± 1.9 | 7.4 ± 0.1 | 5.7 ± 0.2 | 2.5 ± 0.1 | 0.27 ± 0.04 | 2.42 ± 0.27 |
Figure 2IR spectra of VDF-TeFE/PVP/ZnO membranes with various PVP content.
Figure 3XRD patterns of the VDF-TeFE/PVP/ZnO membranes with various PVP contents.
Crystallite size in VDF-TeFE/PVP/ZnO membranes with various PVP contents.
| PVP Content, % | Crystal Size, nm | |
|---|---|---|
| β-Phase VDF-TeFE | ZnO | |
| 0 | 10.5 ± 1.2 | 20.2 ± 1.7 |
| 5 | 9.9 ± 0.9 | 20.9 ± 1.7 |
| 10 | 9.1 ± 0.7 | 20.9 ± 2.0 |
| 20 | 8.4± 1.1 | 20.4 ± 2.1 |
| 40 | 7.2 ± 1.5 | 20.5 ± 1.6 |
Antibacterial activity of VDF-TeFE/PVP/ZnO membranes with various PVP contents.
| Sample | Incubation Time, h | Number of Microorganisms, CFU/mL | Growth Rate on a Control Sample | Growth Rate on Hybrid Samples | Antibacterial Activity |
|---|---|---|---|---|---|
| PVP 0% | 0 | 1.67 × 104 ± 0.15 | 3.071 | 2.74 | 0.33 |
| 24 | 2.00 × 107 ± 0.50 | ||||
| PVP 5% | 0 | 1.40 × 104 ± 0.10 | 2.82 | 0.25 | |
| 24 | 9.17 × 106 ± 0.29 | ||||
| PVP 10% | 0 | 1.43 × 104 ± 0.40 | 2.04 | 1.03 | |
| 24 | 1.53 × 106 ± 0.06 | ||||
| PVP 20% | 0 | 1.60 × 104 ± 0.17 | 1.09 | 1.98 | |
| 24 | 1.97 × 105 ± 0.06 | ||||
| PVP 40% | 0 | 1.67 × 104 ± 0.29 | 0.48 | 2.60 | |
| 24 | 5.00 × 104 ± 1.00 |
Figure 4Photographs of the wounds after 10 days of the experiment: (A)—intact wound, (B)—after contact with the material containing 0 wt% of PVP, (C)—5 wt% of PVP, (D)—10 wt% of PVP, (E)—20 wt% of PVP, (F)—40 wt% of PVP, (G)—control group.